Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation

NCT ID: NCT02256358

Last Updated: 2014-10-20

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Compare the effects of intravenous midazolam and ketamine on emergence agitation after sevoflurane anesthesia

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Emergence agitation is self-limiting aggressive behavior that develops in the early period of awakening from anesthesia. A high level of preoperative anxiety is a risk factor for emergence agitation using Aono's four-point scale. Midazolam and ketamine was administered to the patients to decrease of preoperative anxiety. We aimed to compare the emergence agitation between midazolam group and ketamine group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychomotor Agitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Midazolam

Intravenous 0.1 mg/kg midazolam was administered to the patients as premedication drug before entering operating room.

Group Type ACTIVE_COMPARATOR

Midazolam

Intervention Type DRUG

preoperatively injected intravenous 0.1 mg/kg midazolam

Ketamine

Intravenous 1 mg/kg ketamine was administered to the patients as premedication drug before entering operating room.

Group Type EXPERIMENTAL

Ketamine

Intervention Type DRUG

Preoperatively injected intravenous 1mg/kg ketamine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Midazolam

preoperatively injected intravenous 0.1 mg/kg midazolam

Intervention Type DRUG

Ketamine

Preoperatively injected intravenous 1mg/kg ketamine

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Ketamine HCl

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* American society of anesthesiologists physical status 1-2 aged 2-6 years old, who were scheduled to undergo ophthalmic surgery (\<2hr)

Exclusion Criteria

* children with central nervous system disorders,history of allergy to the study drugs (midazolam and ketamine), history of recent respiratory tract infection
Minimum Eligible Age

2 Years

Maximum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Inje University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ki Hwa Lee

Assistant professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kihwa Lee, MD

Role: STUDY_CHAIR

Haeundae paik hospital, inje university

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012-127

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sevoflurane Induced Emergence Agitation
NCT02022488 COMPLETED PHASE4